Global Non-Vascular Stents Market Poised for Robust Growth, Projected to Reach USD 1.9 Billion by 2032

The global non-vascular stents market is on the verge of significant expansion, expected to achieve a compound annual growth rate (CAGR) of 4.5% from 2022 to 2032. Valued at USD 1.21 billion in 2022, the market is projected to reach an impressive USD 1.9 billion by 2032. This growth is primarily driven by the increasing demand for minimally invasive procedures and advancements in stent technology.

One of the key factors propelling the growth of the non-vascular stents market is the rising preference for minimally invasive surgical techniques. These procedures involve smaller, more precise incisions, resulting in minimal scarring when compared to traditional surgical methods. This not only enhances patient safety but also provides a compelling impetus for the widespread adoption of non-vascular stents. Additionally, the reduced recovery time associated with these surgeries allows for shorter hospital stays, making them a more attractive option for patients.

Moreover, shorter hospital stays significantly decrease the risk of patients contracting hospital-acquired infections, such as bloodstream infections and urinary tract infections. This further fuels the demand for non-vascular stents as healthcare providers and patients seek to minimize potential complications.

A notable driver of the non-vascular stents market is the surge in cases of chronic obstructive pulmonary disease (COPD), which can result from smoking, lung cancer, tracheobronchial malacia, and chemical exposure. The increasing prevalence of COPD is leading to a higher demand for effective treatment options, including non-vascular stents.

As the market continues to evolve, innovations in stent technology are expected to enhance the efficacy and safety of non-vascular stents, thereby attracting more patients and healthcare providers alike.

Key Takeaways:

• Based on product type, the urological stents segment is likely to dominate the non-vascular stents market with a CAGR of 4.3% through 2032.
• The US non-vascular stents market is expected to capture a sizeable non-vascular stents market share accounting for around USD659.1 million by 2032.
• By 2032, the UK non-vascular stents market is expected to be valued at USD 80.6 million, growing at a CAGR of 3.3%.
• With a CAGR of 3.6% during the forecast period, China non-vascular stents market size is predicted to be apprised at USD 128.1 million by 2032.
• The Japan non-vascular stents market, with a CAGR of 3.9%, is projected to garner a worth of USD 109.8 million by 2032.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

Competitive Landscape:

• Some of the leading non-vascular stents companies include Medtronic plc, Glaukos Corporation, Boston Scientific Corporation, ELLA – CS, s.r.o., CONMED Corporation.
• One of the recent developments in the non-vascular stents market is when Medtronic acquired Medicrea, a fully dedicated spinal implant company focused on bringing reliable and cutting-edge technology to the global market.

Key Players:

• Medtronic plc.
• Glaukos Corporation
• Boston Scientific Corporation
• ELLA – CS, s.r.o.
• CONMED Corporation

Key Segments:

By Product:

• Gastrointestinal Stents
  • Biliary
  • Duodenal
  • Colonic
  • Pancreatic
  • Oesophageal Stents
• Pulmonary Stents
  • Silicone Airway
  • Metallic Airway
• Urological Stents
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube